![Katie Aafjes-van Doorn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Katie Aafjes-van Doorn was the founder of Deliberate Solutions, Inc. and held the title of Clinical Lead.
Katie Aafjes-van Doorn active positions
Companies | Position | Start |
---|---|---|
Deliberate Solutions, Inc.
![]() Deliberate Solutions, Inc. Medical/Nursing ServicesHealth Services Deliberate Solutions, Inc. is an American company that specializes in behavioral and physiological biomarkers, feature selection, and multimodal biomarker fusion for the CNS community. The company's Biomarker Discovery and Validation Platform uses state-of-the-art AI and machine learning. The company was founded in 2020 by Jeffrey F. Cohn, Katie Aafjes-van Doorn, Marc Aafjes, and Marcelo Cicconet, with Marc Aafjes serving as the CEO since 2020. | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Deliberate Solutions, Inc.
![]() Deliberate Solutions, Inc. Medical/Nursing ServicesHealth Services Deliberate Solutions, Inc. is an American company that specializes in behavioral and physiological biomarkers, feature selection, and multimodal biomarker fusion for the CNS community. The company's Biomarker Discovery and Validation Platform uses state-of-the-art AI and machine learning. The company was founded in 2020 by Jeffrey F. Cohn, Katie Aafjes-van Doorn, Marc Aafjes, and Marcelo Cicconet, with Marc Aafjes serving as the CEO since 2020. | Health Services |
- Stock Market
- Insiders
- Katie Aafjes-van Doorn